Schonfeld Strategic Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,200
| Closed | -$15.5K | – | 2025 |
|
|
2023
Q2 | $15.5K | Buy |
+1,200
| New | +$15.5K | ﹤0.01% | 1772 |
|
|
2021
Q4 | – | Sell |
-1,360
| Closed | -$50K | – | 2287 |
|
|
2021
Q3 | $50K | Sell |
1,360
-33,973
| -96% | -$1.25M | ﹤0.01% | 1914 |
|
|
2021
Q2 | $1.53M | Buy |
+35,333
| New | +$1.53M | 0.02% | 769 |
|
|
2019
Q1 | – | Sell |
-3,287
| Closed | -$76K | – | 1199 |
|
|
2018
Q4 | $76K | Buy |
+3,287
| New | +$76K | ﹤0.01% | 1015 |
|
|
2018
Q3 | – | Sell |
-32,760
| Closed | -$927K | – | 975 |
|
|
2018
Q2 | $927K | Buy |
+32,760
| New | +$927K | 0.05% | 406 |
|
|
2018
Q1 | – | Sell |
-6,479
| Closed | -$252K | – | 920 |
|
|
2017
Q4 | $252K | Buy |
+6,479
| New | +$252K | 0.02% | 625 |
|